SADAF ZAIDI: Open Payments
NPI 1588315691 · LINCOLN PARK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 24 payments from 10 companies in 2025. Trend: 2023 $45 · 2024 $49 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 6 | $117 |
| Verona Pharma, Inc. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| ABBVIE INC. | 2 | $46 |
| Novo Nordisk Inc | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: Cologuard Collection Kit, Ohtuvayre, VRAYLAR, CAPLYTA, JARDIANCE, Symbravo, Ozempic, Rybelsus.
Industry payments across MI — which companies pay providers there.
